Two New Alzheimer's Drugs Benefit Whites More Than Blacks. Some See That as a Problem.
This article is for VIP members
Printing PJ Media VIP articles requires an active membership. Join VIP for ad-free reading, exclusive columns and full access to the archive.
Become a VIPAlready a member? Sign in on the article page.